Board of Directors

  • Michael Graves
    Chairman, Executive Committee Chair, Compensation Committee Chair, Audit Committee

    Mike has served as a member of Eagle’s board of directors since 2013. Mike is Chairman of the board of directors of Nanocopoeia, Inc., and a member of the board of directors of RiboCor, Inc. Mike has a wide variety of pharmaceutical industry experience including his position as CEO and President of Paddock Laboratories, Inc., and multiple leadership positions leading to President of the Generic Products Division at Par Pharmaceutical from 1998 – 2006.

  • Scott Tarriff
    Chief Executive Officer, Board Member, Executive Committee

    Scott leads Eagle with more than 25 years of industry experience. Scott founded Eagle in 2007 with the objective of utilizing the 505(b)(2) pathway to maximize the potential of proven medicines. Prior to founding the company, Scott held several key executive-level positions at publicly traded companies, including Bristol-Myers Squibb and Par Pharmaceutical. Scott quickly rose through the ranks at Bristol-Myers Squibb prior to joining Par. While at Par, he served as President and Chief

  • Douglas L. Braunstein, J.D.
    Board Member, Compensation Committee

    Doug has over 30 years of industry experience and is currently the managing partner and founder of Hudson Executive Capital LP. During his career at JPMorgan Chase & Co., Doug served as CFO, Vice Chairman, and Head of America’s Investment Banking and Global M&A departments. Doug also served on several committees, including the Operating Committee, Executive Committee, and Investment Bank Management Committee.

  • Richard A. Edlin, J.D.
    Board Member, Nominating and Corporate Governance Committee

    Rich is currently the Vice Chair, Chair of Litigation Practice in New York and the Business & Regulatory Financial Services Litigation Group, and a member of the Executive Committee of the law firm Greenberg Traurig, LLP.

  • Sander Flaum
    Board Member, Nominating and Corporate Governance Committee Chair, Compensation Committee

    Sander has served as a principal of Flaum Navigators, a healthcare consultancy firm that he founded in January 2005. Since August 2004, he has also served as CEO of Flaum Partners, Inc., another healthcare consultancy firm that he founded. From 1991 to 2002, Sander served as CEO of Robert A. Becker EURO/RSCG, a predecessor to Euro RSCG Life.

  • Robert L. Glenning
    Board Member, Nominating and Corporate Governance Committee, Audit Committee

    Bob has over 30 years of experience in the healthcare industry and currently serves as President of the Financial Services Division and CFO at Hackensack Meridian Health, the most comprehensive healthcare delivery network in the state of New Jersey. He previously served as Executive Vice President and CFO of Hackensack University Health Network. From 2002 to 2007, Bob served as EVP and CFO of Kaleida Health, Inc. Prior to Kaleida Health, he served as VP and CEO of Acute Care at Northeast

  • Steven Ratoff
    Board Member, Audit Committee Chair

    Steve has served as a member of our board of directors since Eagle’s inception in 2007.  From 2010, he has served as President and Chief Executive Officer of NovaDel Pharma, Inc., filling a number of executive positions since joining their board of directors in 2005, and is currently serving as its Chairman. Prior to NovaDel, Steve held various executive positions with Cima Labs, Inc., MacroMed, Inc., and Brown-Forman Corporation. In 2004, Steve began his ongoing tenure as a venture

Business Wire InvestorHQsm